|
|
|
| Curative Effect of Budesonide Nebulization Combined with Ambroxol in the Treatment of Pediatric Bronchopneumonia and Its Effect on Serum CRP and PCT Levels |
| LIU Le, WANG Junxia, GAN Xinru, et al |
| General Hospital of Western Theater, Sichuan Chengdu 610000, China |
|
|
|
|
Abstract Objective: To investigate the curative effect of budesonide nebulization combined with ambroxol in the treatment of pediatric bronchopneumonia and its effect on serum CRP and PCT levels. Methods: A total of 186 children with bronchopneumonia treated in our hospital between June 2020 to September 2021 were enrolled and divided into observation group (n=93) and control group (n=93) by random number table method. The control group was treated with budesonide nebulization, while observation group was additionally treated with intravenous drip of ambroxol. The clinical curative effect after treatment, levels of inflammatory factors (CRP, PCT) and immune function (IgG, IgM, IgA) before and after treatment between the groups were compared. Results: After treatment, total response rate of observation group was higher than that of control group (93.55% vs 71.72%, P<0.05). After treatment, disappearance time of clinical symptoms was shorter in observation group than control group (P<0.05). After 5d of treatment, levels of CRP and PCT in both groups were decreased. The difference values of CRP and PCT before and after treatment in observation group were (25.93±4.54) mg/L and (1.03±0.25) μg/L, higher than those in control group [(16.15±3.72) mg/L, (0.84±0.19) μg/L, P<0.05]. After 5d of treatment, levels of IgA, IgM and IgG in both groups were increased. The difference values of IgA, IgM and IgG before and after treatment in observation group were (4.15±0.87) g/L, (0.46±0.13) g/L and (0.63±0.22) g/L, higher than those in control group [(1.67±0.39) g/L, (0.27±0.06) g/L, (0.27±0.08) g/L, P<0.05]. The incidence of adverse reactions between observation group and control group was similar the difference was not statistically significane [9.68% (9 cases) vs 7.53% (7 cases), P>0.05]. Conclusion: Compared with budesonide nebulization alone, curative effect of budesonide nebulization combined with ambroxol is better on children with bronchopneumonia, which can more effectively improve clinical symptoms, inflammatory factors and immune function, with certain safety.
|
|
|
|
|
|
[1] Chen LJ,Li JM,Zhang WD,et al.LncRNA NEAT1 activates MyD88/NF-κB pathway in bronchopneumonia through targeting miR-155-5p[J].Autoimmunity,2021,54(2):104-113.
[2] Ye J,Ye H,Wang M,Zhao Y.Total serum IL-6 and TNF-C levels in children with bronchopneumonia following treatment with methylprednisolone in combination with azithromycin[J].Am Transl Res,2021,13(8):9458-9464.
[3] 雷丽,樊扬,吕洁,等.布地奈德联合氨溴索治疗小儿支气管肺炎的疗效及对相关炎症指标,免疫因子的影响[J].北华大学学报:自然科学版,2020,21(3):366-370.
[4] Ye J,Ye H,Wang M,et al.Total serum IL-6 and TNF-C levels in children with bronchopneumonia following treatment with methylprednisolone in combination with azithromycin[J].Am Transl Res,2021,13(8):9458-9464.
[5] Zhao D,Chen M,Shi K,et al.A long short-term memory-fully connected (LSTM-FC) neural network for predicting the incidence of bronchopneumonia in children[J].Environ Sci Pollut Res Int,2021,28(40):56892-56905.
[6] 李艳华,史鸽,史笑敏.脾多肽注射液联合布地奈德雾化吸入治疗支气管肺炎的效果及对免疫功能的影响[J].广东医学,2020,41(23):2398-2401.
[7] 范旭升,陈杰华.氨溴索联合布地奈德混悬液雾化吸入治疗新生儿肺炎疗效观察[J].海南医学,2020,31(11):1415-1418.
[8] 陈庆元,朱杰军,何文丽.支气管肺炎患儿血清LDH3,CRP及免疫功能变化的临床意义[J].标记免疫分析与临床,2020,27(8):1390-1394.
[9] 王玲莉,瞿色华,王德志.布地奈德、异丙托溴铵联合沙丁胺醇雾化吸入治疗小儿支气管肺炎的效果及对TGF-β1、CRP的影响[J].湖南师范大学学报(医学版),2021,18(4):230-233. |
|
|
|
2023, Vol. 29 
